Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2009
10/13/2009CA2384037C Pyrazolo[4,3-d]pyrimidines
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253766 Thiophene derivatives as factor xia inhibitors
10/08/2009US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090252678 Cox-2-targeted imaging agents
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2685716A1 Compounds for treating muscular dystrophy
10/07/2009EP2106213A2 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
10/07/2009EP1663985B1 Pesticides
10/07/2009EP1506260B1 Trisazo dyes for ink jet printing
10/07/2009CN101553473A Substituted pyrazoles, compositions containing these, method of production and use
10/07/2009CN100546979C 4-[4-(diethylaminoethyl )phenyl]methylene-5-ethoxy-2,4-dihydro-2-phenyl-3H-pyrazolyl -3-one preparation method
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598395 Heterocyclocarboxamide derivatives
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598285 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance
10/06/2009US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009US7597879 selected from manganese cis-urocanate gluconate, manganese cis-urocanate, and manganese cis-urocanate glycinate; reduction of topical peroxide including hydrogen peroxide, reduction of topical inflammation including sunburn, increased sun protection of skin, the reduction of skin wrinkles
10/06/2009CA2427617C Medicinal compositions for concomitant use as anticancer agent
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247586 Carboxamides for controlling micro-organisms in plant and material protection
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247525 Sigma receptor inhibitors
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease
10/01/2009CA2719745A1 Novel p2x7r antagonists and their use
10/01/2009CA2719735A1 Substituted 4-aminocyclohexane derivatives
10/01/2009CA2718727A1 Heterocyclic compound
09/2009
09/30/2009EP2105164A1 Novel P2X7R antagonists and their use
09/30/2009EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein
09/30/2009EP2104663A2 Method for producing substituted pyrazolecarboxylic acid chlorides
09/30/2009CN101547909A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/30/2009CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof
09/30/2009CN101544607A Method for synthesizing 1-aryl pyrazole compound containing trifluoromethylsulfinyl
09/30/2009CN101544606A Malononitrile compound and use thereof
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
09/29/2009US7595337 Mitotic kinesin inhibitors
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
09/29/2009US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/29/2009US7595162 Methods of labeling polynucleotides with energy transfer dyes
09/29/2009CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors
09/29/2009CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas
09/24/2009WO2009117626A2 Methods for making central nervous system agents that are trpv1 antagonists
09/24/2009WO2009116558A1 1-phenyl-5-difluoromethylpyrazole-4-carboxamide derivative and herbicide containing the same as active ingredient
09/24/2009WO2009116435A1 Method for producing fluorine-containing acylacetic acid derivative, method for producing fluorine-containing pyrazolecarboxylic acid ester derivative, and method for producing fluorine-containing pyrazolecarboxylic acid derivative
09/24/2009WO2009116290A1 4-halogenobenzoyl derivatives having sulfoxyimino group and herbicides
09/24/2009WO2009116151A1 1-phenyl-5-difluoromethylpyrazole-4-carboxamide derivatives and herbicides containing the derivatives as the active ingredient
09/24/2009WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
09/24/2009WO2009115252A2 Substituted pyrazolamides and the use thereof
09/24/2009WO2009035949A3 Soluble epoxide hydrolase inhibitors
09/24/2009US20090240061 Method for forming a carbon-carbon or carbon-heteroatom bond
09/24/2009US20090240058 Activator for Peroxisome Proliferator-Activating Receptor Delta
09/24/2009US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
09/24/2009US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
09/24/2009US20090239845 Pyrazole compounds as prostaglandin receptors ligands
09/24/2009US20090239841 Diaryl Ureas as CB1 Antagonists
09/24/2009DE102008015032A1 Substituierte Pyrazolamide und ihre Verwendung Substituted Pyrazolamides and their use
09/24/2009CA2719018A1 Methods for making central nervous system agents that are trpv1 antagonists
09/24/2009CA2718693A1 Substituted pyrazolamides and the use thereof
09/24/2009CA2717922A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
09/23/2009EP2103215A1 Herbicide containing benzoylpyrazole compound
09/23/2009EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/23/2009EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
09/23/2009EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases
09/23/2009EP2102166A2 Process for producing 5-aminopyrazole derivative, and azo dye
09/23/2009EP2102165A2 N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's
09/23/2009EP1709003B1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
09/23/2009EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use
09/23/2009EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
09/23/2009CN101541758A Indazole derivatives that inhibit TRPV1 and uses thereof
09/23/2009CN101541757A Pyrazoline compounds as mineralocorticoid receptor antagonists
09/23/2009CN101541756A Pyrazoles as glucokinase activators
09/23/2009CN101541755A Benzoylpyrazole compounds, process for their production and herbicides containing them
09/23/2009CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/23/2009CN101538243A Malononitrile compound and use thereof
09/23/2009CN100542530C 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/22/2009US7592363 Indazoles
09/22/2009US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
09/22/2009US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease
09/17/2009WO2009112522A1 (E)-N-(2-Amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
09/17/2009WO2009112157A1 Process for the regioselective synthesis of l-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
09/17/2009US20090234135 pyrazolium cation with fluorosulfonate or fluorosulfonylimide anions; use as solvents, catalysts
09/17/2009US20090234117 Pyrazolopyrimidine Derivative
09/17/2009US20090233901 Vla-4 inhibitory drug
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 256